Mankind Pharma P/E Ratio
Mankind Pharma (MANKIND) P/E ratio is 47.03 (High), EPS (TTM) ₹49.28, current price ₹2077.40 on NSE vs historical average P/E of 46.23 (66.7th percentile) — Very High - High growth expectations or significantly overvalued. For live price, revenue and the complete fundamental profile, see MANKIND company profile.
Current Valuation Metrics
Valuation Signal
Sector Context
Earnings Breakdown (TTM)
MANKIND P/E Ratio — Valuation Signal & Historical Context
Mankind Pharma P/E 47.03 vs historical average 46.23, range 32.98–66.85 — signal: Overvalued. Analyse MANKIND FII DII holdings to track promoter, FII and institutional holdings.
- Stock appears overvalued with PE of 47.03, suggesting caution for new investments
Mankind Pharma P/E Ratio Historical Trend
MANKIND annual price-to-earnings ratio — 3 years, EPS and year-end price. Current P/E 47.03 vs historical average 46.23. View Mankind Pharma 52-week for the annual high/low range and current price position.
MANKIND Historical P/E Ratio — EPS, Year-End Price & Valuation
Mankind Pharma annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2025 | 66.85 | 43.1 | ₹2881.05 | NSE | High |
| 2024 | 38.87 | 50.92 | ₹1979.20 | NSE | High |
| 2023 | 32.98 | 43.12 | ₹1422.30 | NSE | High |
MANKIND vs Healthcare Peers — P/E Ratio Comparison
Mankind Pharma P/E 47.03 vs Healthcare average 48.97, median 26.94 — range 1.17–869.57.
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.17 | ₹43 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.93 | ₹1,136 | Low |
| Amwill Health Care | AMWILL | 5.67 | ₹64 | Low |
| Medicamen Organics | MEDIORG | 6.4 | ₹27 | Low |
| Zenith Drugs | ZENITHDRUG | 6.83 | ₹69 | Low |
| Unichem Laboratories | UNICHEMLAB | 7.99 | ₹2,364 | Low |
| Galaxy Medicare | GML | 8.78 | ₹31 | Low |
| Brooks Laboratories | BROOKS | 9.86 | ₹211 | Low |
| Accretion Pharmaceuticals | ACCPL | 10.92 | ₹78 | Low |